Similarly, other mutations such as Y640F in STAT1 or D661V in STAT3, which occur in the SH2 domain or in regions that regulate dimerization, have been reported to enhance STAT activity and are sometimes found in hematologic malignancies and immune disorders (258, 259). This evidence concerns the gene STAT3 and immune system disorder.